Puma Biotechnology (PBYI) Financials: Revenue & Earnings
$544.85M
Market Cap
20.15
P/E
27.78
Forward P/E
45
Score
PBYI price $10.55 -0.36 -3.34%
Stocklytics score rationale: value 52, quality 75, growth 9.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 27700000 | 251000000 | 272260000 | 225110000 | 253155000 | 228031000 | 235637000 | 230468000 | 228371000 |
Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast…
PBYI fair value $10.85. Price $10.55. Price is about fair value.
Below fair value, but more expensive than usual. A smaller discount than on 85% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Average free cash flow, last three years 31.65M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.95% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 51.62M. Net debt -1.09M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | 0.09 | — | 57.50M |
| 2026-08-06 | 0.19 | 0.04 | 56.50M | 53.00M |
| 2026-05-07 | -0.04 | -0.13 | 44.80M | 42.00M |
| 2026-02-26 | 0.29 | 0.24 | 59.90M | 68.62M |
| 2025-11-06 | 0.21 | 0.09 | 51.90M | 51.00M |
| 2025-08-07 | 0.15 | 0.11 | 49.20M | 52.00M |
| 2025-05-08 | 0.10 | 0.02 | 43.10M | 44.55M |
| 2025-02-27 | 0.43 | 0.10 | 59.10M | 52.51M |
| 2024-11-07 | 0.41 | 0.35 | 80.50M | 70.65M |
| 2024-08-01 | -0.05 | -0.10 | 44.40M | 44.70M |
| 2024-05-02 | -0.05 | -0.22 | 43.80M | 41.05M |
| 2024-02-29 | 0.26 | 0.30 | 72.20M | 73.55M |
| 2023-11-02 | 0.12 | 0.08 | 56.10M | 57.95M |
| 2023-08-03 | 0.05 | 0.01 | 54.60M | 51.73M |
| 2023-05-04 | 0.03 | -0.07 | 52.80M | 49.63M |
| 2023-03-02 | -0.12 | 0.06 | 65.70M | 57.06M |
| 2022-11-03 | -0.01 | -0.07 | 57.10M | 50.47M |
| 2022-08-04 | 0.21 | 0.02 | 59.50M | 52.62M |
| 2022-05-05 | -0.08 | -0.17 | 45.70M | 45.07M |
| 2022-03-03 | 0.10 | -0.09 | 55.40M | 47.17M |
| 2021-11-04 | -1.09 | -0.31 | 46.24M | 55.06M |
| 2021-08-05 | -0.13 | -0.27 | 53.38M | 53.00M |
| 2021-05-06 | 0.40 | 0.09 | 98.17M | 69.96M |
| 2021-02-25 | -0.38 | -0.31 | 52.56M | 53.00M |
| 2020-11-05 | -0.79 | -0.39 | 50.75M | 36.69M |
| 2020-08-06 | 0.08 | -0.30 | 70.58M | 264.68M |
| 2020-05-07 | -0.43 | -0.77 | 51.22M | 91.71M |
| 2020-02-20 | -0.29 | -0.48 | 62.92M | 104.15M |
| 2019-11-06 | -0.44 | -0.71 | 56.40M | 90.93M |
| 2019-08-08 | -0.97 | -0.95 | 53.92M | 52.81M |
| 2019-05-09 | -0.26 | -0.68 | 99.10M | 259.10M |
| 2019-02-28 | -0.80 | -0.77 | 71.10M | 68.41M |
| 2018-11-01 | -0.37 | -0.97 | 62.60M | 164.19M |
| 2018-08-09 | -1.17 | -1.26 | 50.77M | 54.67M |
| 2018-05-09 | -0.65 | -0.75 | 66.52M | 102.33M |
| 2018-03-01 | -1.71 | -1.98 | 21.60M | 24.89M |
| 2017-11-09 | -2.07 | -2.75 | 6.08M | 7.57M |
| 2017-08-09 | -2.10 | -2.10 | — | — |
| 2017-05-10 | -1.97 | -1.98 | — | — |
| 2017-03-01 | -2.04 | -2.02 | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-14 | WILSON TROY EDWARD | Sell | 5.00K | $9.10 | 45.50K |
| 2026-09-14 | Cesano Alessandra | Buy | 50.00K | $2.93 | 146.50K |
| 2026-09-14 | Cesano Alessandra | Sell | 62.15K | $9.12 | 566.99K |
| 2026-09-14 | Cesano Alessandra | Sell | 50.00K | $2.93 | 146.50K |
| 2026-07-06 | AUERBACH ALAN H | Sell | 44.06K | $8.26 | 364.05K |
| 2026-07-06 | HUNT DOUGLAS M | Sell | 8.46K | $8.26 | 69.90K |
| 2026-07-06 | NOUGUES MAXIMO F | Sell | 9.39K | $8.26 | 77.56K |
| 2026-06-12 | WILSON TROY EDWARD | Sell | 10.80K | $7.20 | 77.75K |
| 2026-06-12 | Stuglik Brian M | Sell | 8.10K | $7.20 | 58.31K |
| 2026-06-12 | Senderowicz Adrian | Sell | 27.00K | $7.20 | 194.31K |
| 2026-06-12 | MOYES JAY M | Sell | 22.00K | $7.22 | 158.80K |
| 2026-06-12 | Dorval Allison | Sell | 11.61K | $7.20 | 83.58K |
| 2026-06-11 | WILSON TROY EDWARD | Buy | 27.00K | — | — |
| 2026-06-11 | Stuglik Brian M | Buy | 27.00K | — | — |
| 2026-06-11 | Senderowicz Adrian | Buy | 27.00K | $7.20 | 194.31K |
| 2026-06-11 | MILLER MICHAEL PATRICK | Buy | 27.00K | — | — |
| 2026-06-11 | MOYES JAY M | Buy | 27.00K | — | — |
| 2026-06-11 | Dorval Allison | Buy | 27.00K | — | — |
| 2026-06-11 | Cesano Alessandra | Buy | 27.00K | — | — |
| 2026-02-18 | AUERBACH ALAN H | Buy | 159.78K | — | — |
| 2026-02-18 | AUERBACH ALAN H | Buy | 227.47K | $6.68 | 1.52M |
| 2026-02-18 | HUNT DOUGLAS M | Buy | 49.39K | — | — |
| 2026-02-18 | HUNT DOUGLAS M | Buy | 70.32K | $6.68 | 469.74K |
| 2026-02-18 | NOUGUES MAXIMO F | Buy | 46.74K | — | — |
| 2026-02-18 | NOUGUES MAXIMO F | Buy | 66.54K | $6.68 | 444.49K |
| 2026-01-07 | AUERBACH ALAN H | Sell | 18.01K | $5.88 | 105.89K |
| 2026-01-07 | HUNT DOUGLAS M | Sell | 5.01K | $5.88 | 29.48K |
| 2026-01-07 | NOUGUES MAXIMO F | Sell | 6.41K | $5.88 | 37.65K |
| 2026-01-06 | AUERBACH ALAN H | Sell | 16.94K | $5.84 | 98.99K |
| 2026-01-06 | HUNT DOUGLAS M | Sell | 3.97K | $5.84 | 23.22K |
| 2026-01-06 | NOUGUES MAXIMO F | Sell | 4.54K | $5.84 | 26.53K |
| 2025-11-11 | MILLER MICHAEL PATRICK | Sell | 20.00K | $4.86 | 97.23K |
| 2025-07-18 | Cesano Alessandra | Sell | 27.00K | $3.37 | 90.91K |
| 2025-07-09 | NOUGUES MAXIMO F | Sell | 3.94K | $3.54 | 13.91K |
| 2025-07-09 | HUNT DOUGLAS M | Sell | 3.44K | $3.54 | 12.17K |
| 2025-07-09 | AUERBACH ALAN H | Sell | 21.58K | $3.54 | 76.29K |
| 2025-07-08 | NOUGUES MAXIMO F | Sell | 5.59K | $3.53 | 19.74K |
| 2025-07-08 | HUNT DOUGLAS M | Sell | 4.37K | $3.53 | 15.45K |
| 2025-07-08 | AUERBACH ALAN H | Sell | 25.59K | $3.53 | 90.42K |
| 2025-06-13 | WILSON TROY EDWARD | Sell | 10.80K | $3.40 | 36.72K |
| 2025-06-13 | Stuglik Brian M | Sell | 8.10K | $3.39 | 27.46K |
| 2025-06-13 | Senderowicz Adrian | Sell | 27.00K | $3.40 | 91.80K |
| 2025-06-13 | MOYES JAY M | Sell | 22.00K | $3.40 | 74.80K |
| 2025-06-13 | Dorval Allison | Sell | 11.61K | $3.40 | 39.47K |
| 2025-06-13 | Cesano Alessandra | Sell | 12.15K | $3.40 | 41.31K |
| 2025-06-11 | MILLER MICHAEL PATRICK | Buy | 27.00K | — | — |
| 2025-06-11 | Senderowicz Adrian | Buy | 27.00K | — | — |
| 2025-06-11 | MOYES JAY M | Buy | 27.00K | — | — |
| 2025-06-11 | Dorval Allison | Buy | 27.00K | — | — |
| 2025-06-11 | Stuglik Brian M | Buy | 27.00K | — | — |
| 2025-06-11 | WILSON TROY EDWARD | Buy | 27.00K | — | — |
| 2025-06-11 | Cesano Alessandra | Buy | 27.00K | — | — |
| 2025-02-07 | NOUGUES MAXIMO F | Buy | 61.46K | — | — |
| 2025-02-07 | NOUGUES MAXIMO F | Buy | 85.07K | $2.78 | 236.49K |
| 2025-02-07 | Ludwig Jeffrey Jerome | Buy | 47.84K | — | — |
| 2025-02-07 | Ludwig Jeffrey Jerome | Buy | 66.22K | $2.78 | 184.09K |
| 2025-02-07 | HUNT DOUGLAS M | Buy | 48.12K | — | — |
| 2025-02-07 | HUNT DOUGLAS M | Buy | 66.60K | $2.78 | 185.16K |
| 2025-02-07 | AUERBACH ALAN H | Buy | 198.40K | — | — |
| 2025-02-07 | AUERBACH ALAN H | Buy | 274.62K | $2.78 | 763.45K |
| 2025-01-02 | NOUGUES MAXIMO F | Sell | 10.23K | $3.15 | 32.23K |
| 2025-01-02 | Ludwig Jeffrey Jerome | Sell | 9.44K | $3.15 | 29.74K |
| 2025-01-02 | HUNT DOUGLAS M | Sell | 8.63K | $3.15 | 27.21K |
| 2025-01-02 | AUERBACH ALAN H | Sell | 33.84K | $3.15 | 106.66K |
| 2024-08-12 | MILLER MICHAEL PATRICK | Sell | 23.36K | $3.49 | 81.47K |
| 2024-07-17 | NOUGUES MAXIMO F | Sell | 4.16K | $3.70 | 15.38K |
| 2024-07-17 | Ludwig Jeffrey Jerome | Sell | 2.60K | $3.70 | 9.62K |
| 2024-07-17 | HUNT DOUGLAS M | Sell | 3.64K | $3.70 | 13.46K |
| 2024-07-17 | AUERBACH ALAN H | Sell | 21.92K | $3.70 | 81.13K |
| 2024-07-02 | NOUGUES MAXIMO F | Sell | 5.29K | $3.27 | 17.31K |
| 2024-07-02 | Ludwig Jeffrey Jerome | Sell | 6.05K | $3.27 | 19.78K |
| 2024-07-02 | HUNT DOUGLAS M | Sell | 4.35K | $3.27 | 14.21K |
| 2024-07-02 | AUERBACH ALAN H | Sell | 18.89K | $3.27 | 61.73K |
| 2024-06-18 | WILSON TROY EDWARD | Buy | 27.00K | — | — |
| 2024-06-18 | Stuglik Brian M | Buy | 27.00K | — | — |
| 2024-06-18 | Senderowicz Adrian | Buy | 27.00K | — | — |
| 2024-06-18 | MILLER MICHAEL PATRICK | Buy | 27.00K | — | — |
| 2024-06-18 | MOYES JAY M | Buy | 27.00K | — | — |
| 2024-06-18 | Dorval Allison | Buy | 27.00K | — | — |
| 2024-06-18 | Cesano Alessandra | Buy | 27.00K | — | — |
| 2024-06-13 | WILSON TROY EDWARD | Sell | 27.00K | $3.33 | 89.90K |
| 2024-06-13 | Stuglik Brian M | Sell | 9.90K | $3.39 | 33.53K |
| 2024-06-13 | Senderowicz Adrian | Sell | 27.00K | $3.33 | 89.82K |
| 2024-06-13 | MOYES JAY M | Sell | 22.00K | $3.34 | 73.47K |
| 2024-06-13 | Dorval Allison | Sell | 11.00K | $3.37 | 37.10K |
| 2024-03-15 | AUERBACH ALAN H | Buy | 6.58K | — | — |
| 2024-03-15 | AUERBACH ALAN H | Buy | 9.05K | $5.00 | 45.23K |
| 2024-02-12 | Wong Alvin F | Buy | 43.31K | — | — |
| 2024-02-12 | Wong Alvin F | Buy | 59.95K | $6.36 | 381.26K |
| 2024-02-12 | NOUGUES MAXIMO F | Buy | 43.31K | — | — |
| 2024-02-12 | NOUGUES MAXIMO F | Buy | 59.95K | $6.36 | 381.26K |
| 2024-02-12 | Ludwig Jeffrey Jerome | Buy | 27.07K | — | — |
| 2024-02-12 | Ludwig Jeffrey Jerome | Buy | 37.47K | $6.36 | 238.28K |
| 2024-02-12 | AUERBACH ALAN H | Buy | 160.80K | — | — |
| 2024-02-12 | AUERBACH ALAN H | Buy | 222.57K | $6.36 | 1.42M |
| 2024-02-12 | HUNT DOUGLAS M | Buy | 37.89K | — | — |
| 2024-02-12 | HUNT DOUGLAS M | Buy | 52.45K | $6.36 | 333.59K |
| 2024-01-03 | Wong Alvin F | Sell | 7.73K | $4.49 | 34.69K |
| 2024-01-03 | Ludwig Jeffrey Jerome | Sell | 12.96K | $4.49 | 58.12K |
| 2024-01-03 | AUERBACH ALAN H | Sell | 41.40K | $4.49 | 185.70K |
Latest filed quarter: Q2 2026.
Institutions holding: 166, holders +7 vs prior quarter. Ownership 76.19%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | 4.13M | 0 | 0.00% | 33.50M |
| BLACKROCK, INC. | 3.80M | 205.78K | +5.72% | 30.86M |
| AMERICAN CENTURY COMPANIES INC | 2.32M | 403.65K | +21.06% | 18.82M |
| ACADIAN ASSET MANAGEMENT LLC | 2.05M | 11.76K | +0.58% | 16.65M |
| RENAISSANCE TECHNOLOGIES LLC | 1.84M | -106.20K | -5.47% | 14.89M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.84M | 17.96K | +0.99% | 14.89M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.83M | 90.95K | +5.24% | 14.81M |
| LSV ASSET MANAGEMENT | 1.62M | 435.11K | +36.78% | 13.12M |
| DIMENSIONAL FUND ADVISORS LP | 1.52M | 81.91K | +5.70% | 12.31M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.34M | 322.06K | +31.66% | 10.86M |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 1.12M | -14.39K | -1.26% | 9.11M |
| STATE STREET CORP | 952.16K | 34.58K | +3.77% | 7.72M |
| KENNEDY CAPITAL MANAGEMENT LLC | 873.25K | -16.35K | -1.84% | 7.08M |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 791.62K | 16.27K | +2.10% | 6.42M |
| RITHOLTZ WEALTH MANAGEMENT | 749.80K | -24.51K | -3.17% | 6.08M |
| AQR CAPITAL MANAGEMENT LLC | 725.19K | -75.00K | -9.37% | 5.88M |
| GOLDMAN SACHS GROUP INC | 669.16K | -563 | -0.08% | 5.43M |
| NORTHERN TRUST CORP | 652.39K | 10.63K | +1.66% | 5.29M |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 642.95K | -139.85K | -17.87% | 5.21M |
| UBS GROUP AG | 636.76K | 102.53K | +19.19% | 5.16M |
| MILLENNIUM MANAGEMENT LLC | 602.24K | -875.28K | -59.24% | 4.88M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 532.45K | -5.71K | -1.06% | 4.32M |
| SEI INVESTMENTS CO | 418.67K | -89.51K | -17.61% | 3.40M |
| GLOBEFLEX CAPITAL L P | 382.81K | 33.16K | +9.48% | 3.10M |
| BANK OF NEW YORK MELLON CORP | 360.73K | 12.85K | +3.69% | 2.93M |
Puma Biotechnology, Inc. (PBYI) trades at $10.55, with a market cap of $544.85M and a trailing P/E of 20.15. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 27700000 | 251000000 | 272260000 | 225110000 | 253155000 | 228031000 | 235637000 | 230468000 | 228371000 |
Insights · Dividends · Forecast · Financials · Learn
$544.85M
Market Cap
20.15
P/E
27.78
Forward P/E
45
Score